Hialohifomicosis (página 2)

36. Galimberti, R., et al., Cutaneous aspergillosis:
a report of six cases. Br J Dermatol, 1998. 139(3): p.
522-6.

37. Nucci, M. and E. Anaissie, Cutaneous infection
by Fusarium species in healthy and immunocompromised hosts:
implications for diagnosis and management. Clin Infect Dis,
2002. 35(8): p. 909-20.

38. Martino, P., et al., Clinical patterns of
Fusarium infections in immunocompromised patients. J Infect,
1994. 28 Suppl 1: p. 7-15.

39. Venditti, M., et al., Invasive Fusarium solani
infections in patients with acute leukemia. Rev Infect Dis,
1988. 10(3): p. 653-60.

40. Glasgow, G.P., J.E. Marks, and J.H. Ogura, An
endolaryngeal brachytherapy mould for a carcinoma of the larynx
recurrent after surgery and radiation. Laryngoscope, 1983.
93(1): p. 111-2.

41. Lionakis, M.S. and D.P. Kontoyiannis, Fusarium
infections in critically ill patients. Semin Respir Crit
Care Med, 2004. 25(2): p. 159-69.

42. Guarro, J., et al., Mixed infection caused by
two species of Fusarium in a human immunodeficiency
virus-positive patient. J Clin Microbiol, 2000. 38(9): p.
3460-2.

43. Hansson, C., K. Rosen, and I. Braide, Fusarium
infection with unusual skin lesions in a patient with acute
lymphocytic leukemia. Dermatology, 1995. 191(4): p.
333-5.

44. Watsky, K.L., Sporotrichoid nodules in an
immunocompromised host. Cutaneous emboli of Fusarium. Arch
Dermatol, 1995. 131(11): p. 1329, 1330.

45. Collins, M.S. and M.G. Rinaldi, Cutaneous
infection in man caused by Fusarium moniliforme.
Sabouraudia, 1977. 15(2): p. 151-60.

46. Pereiro, M., Jr., J. Labandeira, and J. Toribio,
Plantar hyperkeratosis due to Fusarium verticillioides in a
patient with malignancy. Clin Exp Dermatol, 1999. 24(3): p.
175-8.

47. Biglan AW, J.H.P.W.S.,
Endophthalmitis.En:PediatricInfectious Diseases,
Principlesandpractice. 2002. 2a ed.: p.;p.1074-9.

48. Graybill, J.R., Antifungal drugs and
resistance. Adv Exp Med Biol, 1995. 390: p.
217-34.

49. Walsh, T.J., et al., Amphotericin B lipid
complex for invasive fungal infections: analysis of safety and
efficacy in 556 cases. Clin Infect Dis, 1998. 26(6): p.
1383-96.

50. Wolff, M.A. and R. Ramphal, Use of amphotericin
B lipid complex for treatment of disseminated cutaneous fusarium
infection in a neutropenic patient. Clin Infect Dis, 1995.
20(6): p. 1568-9.

51. Letscher-Bru, V., et al., Successful outcome of
treatment of a disseminated infection due to Fusarium dimerum in
a leukemia patient. J Clin Microbiol, 2002. 40(3): p.
1100-2.

52. Walsh, T.J. and A.H. Groll, Emerging fungal
pathogens: evolving challenges to immunocompromised patients for
the twenty-first century. Transpl Infect Dis, 1999. 1(4): p.
247-61.

53. Ghannoum, M.A. and D.M. Kuhn, Voriconazole —
better chances for patients with invasive mycoses. Eur J Med
Res, 2002. 7(5): p. 242-56.

54. Consigny, S., et al., Successsful voriconazole
treatment of disseminated fusarium infection in an
immunocompromised patient. Clin Infect Dis, 2003. 37(2): p.
311-3.

55. Paphitou, N.I., et al., In vitro activities of
investigational triazoles against Fusarium species: effects of
inoculum size and incubation time on broth microdilution
susceptibility test results. Antimicrob Agents Chemother,
2002. 46(10): p. 3298-300.

56. Linares, M.J., et al., Susceptibility of
filamentous fungi to voriconazole tested by two microdilution
methods. J Clin Microbiol, 2005. 43(1): p. 250-3.

57. PerfectJ., In vitro activities of investigation
al triazoles against Fusarium species:effects of inoculum size
and incubation time on broth microdilution susceptibility test
results. Clin Infect Dis, 2005. 40(Supl6):
p.:S401-8.

58. Raad, II, et al., Posaconazole as salvage
treatment for invasive fusariosis in patients with underlying
hematologic malignancy and other conditions. Clin Infect
Dis, 2006. 42(10): p. 1398-403.

59. Nucci, M., et al., Outcome predictors of 84
patients with hematologic malignancies and Fusarium
infection. Cancer, 2003. 98(2): p. 315-9.

60. Perdomo, H., et al., Spectrum of clinically
relevant Acremonium species in the United States. J Clin
Microbiol. 49(1): p. 243-56.

61. Lau, Y.L., et al., Invasive Acremonium
falciforme infection in a patient with severe combined
immunodeficiency. Clin Infect Dis, 1995. 20(1): p.
197-8.

62. Hoog, G., J. Guarro, J. Gené, y MJ Figueras,
Atlas de los Hongos clínicas. 2000. 2 ª ed,
vol. 1.

63. DH, L., Los Hongos medicamente importantes, una
guia de identificacion AMS Washinton D.C., 1995. 3era
edicion.

64. Garzoni, C. and J. Garbino, New azoles as first
line therapy for Paecilomyces lilacinus in transplant
patients. Transpl Infect Dis, 2008. 10(2): p.
149-50.

65. Pastor, F.J. and J. Guarro, Clinical
manifestations, treatment and outcome of Paecilomyces lilacinus
infections. Clin Microbiol Infect, 2006. 12(10): p.
948-60.

66. Cortez, K.J., et al., Infections caused by
Scedosporium spp. Clin Microbiol Rev, 2008. 21(1): p.
157-97.

67. Nucci, M., Emerging moulds: Fusarium,
Scedosporium and Zygomycetes in transplant recipients. Curr
Opin Infect Dis, 2003. 16(6): p. 607-12.

68. Caston, J.J., et al., Clinical differences
between invasive pulmonary infection by Scedosporium apiospermum
and invasive pulmonary aspergillosis. Mycoses. 54(5): p.
e468-73.

69. Perfect, J.R., et al., Voriconazole treatment
for less-common, emerging, or refractory fungal infections.
Clin Infect Dis, 2003. 36(9): p. 1122-31.

70. Kuhls, K., et al., Molecular reidentification of
human pathogenic Trichoderma isolates as Trichoderma
longibrachiatum and Trichoderma citrinoviride. Med Mycol,
1999. 37(1): p. 25-33.

71. Alanio, A., et al., Invasive pulmonary infection
due to Trichoderma longibrachiatum mimicking invasive
Aspergillosis in a neutropenic patient successfully treated with
voriconazole combined with caspofungin. Clin Infect Dis,
2008. 46(10): p. e116-8.

72. Lagrange-Xelot, M., et al., Trichoderma
fungaemia in a neutropenic patient with pulmonary cancer and
human immunodeficiency virus infection. Clin Microbiol
Infect, 2008. 14(12): p. 1190-2.

73. Vignon, M., et al., Disseminated Scopulariopsis
brevicaulis infection in an allogeneic stem cell recipient.
Bone Marrow Transplant. 46(9): p. 1276-7.

74. LiuK, H., .AmJClinPathol.,
PerfectJR,SchellWA.Morphologic criteria for the preliminary
identification of Fusarium, Paecilomyces and Acremonium species
by histopathology. 1998(109: .): p. 45-54.

Autor:

Lilia Mercedes Acevedo Almendarez

Pasante de la Maestría en Micología
Medica, Modalidad para extranjeros, julio 2012.Buenos Aires,
Argentina.

Maestría en Micología
Médica

Director: Dr. Ricardo Negroni

Coordinadores: Dra. Alicia
Arechavala

Dr. Gustavo E. Giusiano

BUENOS AIRES ARGENTINA , JULIO 2012

UNIVERSIDAD DEL NORDESTE

FACULTAD DE MEDICINA